Weight loss on a GLP-1: the nutrition nobody covers

Semaglutide, tirzepatide, and whatever arrives next. Some act on GLP-1 receptors, some on GLP-1 and GIP together. The part that concerns me is the same in all of them: intake falls fast, and the body does not give up fat alone.

I am a sports nutritionist. I spend most of the year making weight for people who get punched for a living, which is the most aggressive form of weight management that exists under supervision. The private clients came later, referred by athletes, and several of them arrived already on an injection.

I did not recommend it to any of them. That decision belongs to a doctor, and so do the dose and the stopping. What was missing was everything around it.

Why this section exists

There is a great deal written about these drugs. Almost all of it is written by people interested in the drug.

The gap is on the other side. Once the prescription exists and the appetite is gone, someone has to answer what to eat, how to reach a protein target when nothing appeals, what disappears from the diet when total intake halves, and how to arrive at the lower weight still strong enough to enjoy it.

That is a nutrition problem and it has been left largely unattended.

The thing I keep repeating

Fast weight loss has never taken fat alone, on any method, in any decade. What is different now is the speed, and the fact that the same suppression making the loss easy also makes protein hard to eat.

A scale reports one number for two opposite outcomes. Two people down 8 kg look identical on it, and one of them is in trouble.

Written here so far

If you compete in a tested sport

Different rules, different consequences, and this section is not written for you. GLP-1 drugs are not on the WADA Prohibited List, but they sit in the Monitoring Programme, which is where substances go while WADA gathers data on how often they turn up and in which sports. Both semaglutide and tirzepatide were placed there in 2024, and the WADA Executive Committee confirmed on 10 September 2026 that they stay in the Monitoring Programme for the 2027 List rather than moving across.

Monitoring is not a clearance. It is a waiting room. If you are tested, start at the anti-doping section and speak to your own national organisation before anything else.

A note on what this is not

Nothing here tells you how to lose weight faster. The drug is already doing that and it does not need help from me.

Everything here is about what the loss is made of, which is the question that decides whether you are still strong in a year, and which almost nobody is being asked.